Croton-on-Hudson, NY, United States of America

Richard Tavare

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Richard Tavare: Innovator in Antibody Research

Introduction

Richard Tavare is a prominent inventor based in Croton-on-Hudson, NY (US). He has made significant contributions to the field of antibody research, particularly in the development of anti-CD8 antibodies. With a total of 5 patents to his name, Tavare's work has advanced the understanding and application of these antibodies in medical imaging and diagnostics.

Latest Patents

Tavare's latest patents focus on anti-CD8 antibodies and their various applications. These include radiolabeled anti-CD8 antibodies and fluorescently labeled anti-CD8 antibodies, which are essential for imaging purposes. His patents provide methods for detecting the presence of CD8 proteins in a subject or sample, showcasing the innovative approaches he has developed in this area.

Career Highlights

Richard Tavare is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to push the boundaries of antibody research. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications in immunology.

Collaborations

Throughout his career, Tavare has collaborated with notable colleagues, including Dangshe Ma and William C Olson. These partnerships have enhanced the research and development of innovative solutions in the field of antibody technology.

Conclusion

Richard Tavare's contributions to the field of antibody research, particularly through his patents and collaborations, highlight his role as a leading inventor. His work continues to impact the medical field, particularly in the detection and imaging of CD8 proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…